Question 1

Does Frontier Capital Management own RARE stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Frontier Capital Management holds 2,847,936 shares of RARE (Ultragenyx Pharmaceutical), worth $95.1M.

Question 2

How many shares of RARE does Frontier Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Frontier Capital Management holds 2,847,936 shares of RARE (Ultragenyx Pharmaceutical).

Question 3

What is Frontier Capital Management's RARE position worth?

Accepted Answer

As of its Q2 2026 13F, Frontier Capital Management's RARE position is worth $95.1M.

Question 4

Is Frontier Capital Management buying or selling RARE?

Accepted Answer

In Q2 2026, Frontier Capital Management increased its RARE position by 656,754 shares (+30.0%).

Question 5

When did Frontier Capital Management first buy RARE?

Accepted Answer

Frontier Capital Management first reported RARE in its Q2 2025 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.8M	+30.0%	$95.1M	0.9%	$33.39	53
2026-Q1	Increased	2.2M	+11.5%	$45.9M	0.5%	$20.95	39
2025-Q4	Increased	2M	+83.8%	$45.2M	0.5%	$23.00	54
2025-Q3	Increased	1.1M	+103.5%	$32.2M	0.3%	$30.08	56
2025-Q2	New	525,464	-	$19.1M	0.2%	$36.36	47